ARCHIVES

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

This article is from The Cancer Letter archive.

Vol. 11 No. 40 | October 18, 1985

Download PDF Visit The Full Archive

Related Articles

NIH Revises Application Receipt Dates

November 22, 1985

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994

DCT to Fund 11 Surgical Oncology Grants. Consider Switching $700,000 To Program Project Renewals

November 2, 1979

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

In Brief: NCAB To Hear Report On Controversial Special Virus Cancer Program March 19; Centers, Bladder Project Also On Agenda

March 8, 1974